We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Asuragen to Provide GLP Laboratory Testing Services to a Biotechnology Organization

Listen with
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: Less than a minute

Asuragen, Inc. has announced that it was selected to provide GLP compliant laboratory testing to assist in gene expression studies being conducted by Millennium Pharmaceuticals of Cambridge, MA.

Asuragen, a cGMP/GLP facility, is dedicated to helping the scientific community and industry to discover and develop new products for the advancement of cancer research and companion diagnostics.

“We are committed to applying our RNA expertise to produce the data quality required in clinical studies with organizations such as Millennium and believe that research like this may enable companion diagnostics and support the value of personalized medicine,” commented Scott Hunicke-Smith, V.P. and General Manager of Asuragen Services.